Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

Lockheed Martin, Weak Fiscal Q2

The Motley Fool on MSN · 8h
Lockheed Martin Reports Weak Fiscal Q2
Key Points - Earnings per share fell sharply to $1.46, missing analyst estimates and reflecting significant program charges.- Revenue stayed flat at $18.2 billion but came in below expectations, while operating profit dropped by 65 % compared to the prior year.
Yahoo Finance · 16h
Lockheed Martin Corp (LMT) Q2 2025 Earnings Call Highlights: Navigating Challenges with ...
Despite significant charges and tax uncertainties, Lockheed Martin Corp (LMT) reaffirms its sales guidance and showcases strong shareholder returns and operational efficiency.
Seeking Alpha · 10h
Lockheed Martin Q2: The Quarter That Wasn't Supposed To Be Weak
Lockheed Martin faces $1.8B charges, negative cash flow, and a 10% stock drop despite strong demand. Find out why LMT stock is a Buy.
4h
1LMT : Lockheed Martin Under Intense Wall Street Pressure On Mounting Program Risks,...
Lockheed Martin faces Wall Street pressure after mixed Q2 results and $1.6B in charges. Goldman Sachs analyst reiterates Sell ...
2h
Lockheed Martin: The Post-Earnings Plunge Is A Golden (Dome) Buying Opportunity
Lockheed Martin's stock dip post-earnings presents a buy opportunity with strong demand, growth catalysts, and a 22-year ...
18h
Lockheed Martin Q2 profit plunges 80% on $1.6 billion hit from secret project
The company also lowered its full-year 2025 operating profit forecast by $1.5 billion, or 18%, now projecting $6.65 billion ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy